Financial results - EUROPHARMEDTECH SRL

Financial Summary - Europharmedtech Srl
Unique identification code: 36368233
Registration number: J2022001873087
Nace: 7499
Sales - Ron
-
Net Profit - Ron
-10.279
Employees
1
Open Account
Company Europharmedtech Srl with Fiscal Code 36368233 recorded a turnover of 2024 of - , with a net profit of -10.279 and having an average number of employees of 1. The company operates in the field of Alte activităţi profesionale, stiinţifice şi tehnice n.c.a. having the NACE code 7499.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Europharmedtech Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 10.025 10.469 4.006 4.796 11.916 0 0 0 0
Total Income - EUR - 10.067 10.851 4.163 5.484 12.476 430 1.237 0 0
Total Expenses - EUR - 1.544 5.988 2.667 77.034 61.037 15.077 12.050 3.689 10.279
Gross Profit/Loss - EUR - 8.524 4.862 1.496 -71.550 -48.561 -14.648 -10.813 -3.689 -10.279
Net Profit/Loss - EUR - 8.223 4.540 1.376 -71.645 -48.884 -14.648 -10.813 -3.689 -10.279
Employees - 0 0 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Europharmedtech Srl

Rating financiar

Financial Rating -
EUROPHARMEDTECH SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Europharmedtech Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Europharmedtech Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Europharmedtech Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Europharmedtech Srl - CUI 36368233

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 701 0 0 61.484 53.581 45.806 39.507 39.254 38.890
Current Assets - 9.252 14.442 15.541 43.594 18.247 15.548 15.856 16.590 16.287
Inventories - 0 0 0 22.419 14.726 14.400 14.531 14.487 14.406
Receivables - 59 2.886 0 8.902 2.526 981 1.325 1.563 1.727
Cash - 9.193 11.557 15.541 12.274 995 167 0 540 153
Shareholders Funds - 9.559 13.937 15.057 -56.880 -104.686 -117.013 -128.189 -131.490 -141.034
Social Capital - 1.336 1.313 1.289 1.264 1.240 1.213 1.217 1.213 1.206
Debts - 394 505 485 162.078 176.515 178.367 183.552 187.333 196.210
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7499 - 7499"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 16.287 euro in 2024 which includes Inventories of 14.406 euro, Receivables of 1.727 euro and cash availability of 153 euro.
The company's Equity was valued at -141.034 euro, while total Liabilities amounted to 196.210 euro. Equity decreased by -10.279 euro, from -131.490 euro in 2023, to -141.034 in 2024.

Risk Reports Prices

Reviews - Europharmedtech Srl

Comments - Europharmedtech Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.